Aligos Therapeutics (ALGS)
NASDAQ:ALGS
Holding ALGS?
Track your performance easily

Aligos Therapeutics (ALGS) Income Statement

118 Followers

Aligos Therapeutics Income Statement

Last quarter (Q3 2024), Aligos Therapeutics's total revenue was $1.25M, a decrease of -61.41% from the same quarter last year. In Q3, Aligos Therapeutics's net income was $-19.26M. See Aligos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 5.69M$ 15.53M$ 13.91M--$ 0.00
Cost of Revenue
------
Gross Profit
$ 1.08M$ 6.19M----
Operating Expense
$ 100.58M$ 103.66M$ 111.49M$ 132.68M$ 97.83M$ 54.04M
Operating Income
$ -94.59M$ -88.13M$ -97.58M$ -128.32M$ -97.83M$ -54.04M
Net Non Operating Interest Income Expense
$ 157.00K$ -1.24M$ -1.64M$ -15.00K$ -9.00K$ 1.86M
Other Income Expense
$ -2.32M$ -9.34M$ -13.91M$ -4.25M$ -68.00K$ 302.00K
Pretax Income
$ -76.68M$ -86.88M$ -95.94M$ -128.19M$ -108.38M$ -52.18M
Tax Provision
$ 274.00K$ 795.00K$ 106.00K$ 143.00K$ 161.00K$ 85.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -76.95M$ -87.68M$ -96.05M$ -128.33M$ -108.54M$ -52.26M
Basic EPS
$ -7.57$ -34.00$ -2.25$ -3.22$ -10.87$ -2.47
Diluted EPS
$ -7.57$ -34.00$ -2.25$ -3.22$ -10.87$ -2.47
Basic Average Shares
$ 446.29M$ 64.26M$ 42.70M$ 39.86M$ 9.99M$ 21.17M
Diluted Average Shares
$ 446.49M$ 64.26M-$ 39.86M$ 9.99M$ 21.17M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 100.58M$ 103.66M$ 111.49M$ 132.68M$ 97.83M$ 54.04M
Net Income From Continuing And Discontinued Operation
$ -76.95M$ -87.68M$ -96.05M$ -128.33M$ -108.54M$ -52.26M
Normalized Income
$ -76.92M$ -68.64M---$ -52.26M
Interest Expense
------
EBIT
$ -107.52M$ -88.13M$ -97.58M$ -128.32M$ -97.83M$ -54.04M
EBITDA
$ -104.81M$ -85.06M$ -93.91M$ -124.54M$ -94.51M$ -51.74M
Currency in USD

Aligos Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis